Answers are grounded in this paper and cite their sources.
The authors emphasize that non-anaesthesiologists administering propofol for gastrointestinal endoscopy in Singapore must undergo specialized training and accreditation to safely manage its narrow therapeutic margin and potential cardiorespiratory complications.
Dear Editor, Propofol is a potent intravenous sedative-hypnotic agent. Its popularity for sedation has increased in the last 3 decades because of its smooth, rapid onset of action and fast post-procedural recovery.1 Nonetheless, propofol depresses cardiorespiratory function and could result in life-threatening adverse effects. A workgroup, mainly consisting of gastroenterologists and general surgeons, developed guidelines
No takes yet. Share an insight, caveat, or question.
Chua et al. (2022) conducted a letter in Sedation for gastrointestinal endoscopy. Non-anaesthesiologist-administered propofol was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: